Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Neuroimage. Clinical|December 28, 2020
GAMER MRI: Gated-attention mechanism ranking of multi-contrast MRI in brain pathologyPo-Jui Lu, Youngjin Yoo, Reza Rahmanzadeh, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 10, 2022
Multimodal Investigation of Neuroinflammation in Aviremic Patients With HIV on Antiretroviral Therapy and HIV Elite ControllersHasan Sari, Riccardo Galbusera, Guillaume Bonnier, et al.
Neurology|June 5, 2021
Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple SclerosisPietro Maggi, Jens Kuhle, Sabine Schädelin, et al.
Annals of Neurology|June 17, 2022
A New Advanced MRI Biomarker for Remyelinated Lesions in Multiple SclerosisReza Rahmanzadeh, Riccardo Galbusera, Po-Jui Lu, et al.
Cell Metabolism|November 20, 2021
Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular contextMarcel Morgenstern, Christian D Peikert, Philipp Lübbert, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 28, 2025
Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS CohortGiulio Disanto, Sabine Schaedelin, Johanna Oechtering, et al.
Annals of Neurology|May 31, 2021
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple SclerosisJohanna Oechtering, Sabine Schaedelin, Pascal Benkert, et al.
JAMA Neurology|February 6, 2023
Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple SclerosisStephanie Meier, Eline A J Willemse, Sabine Schaedelin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 3, 2025
Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple SclerosisJohanna Oechtering, Sabine Anna Schaedelin, Kerstin Stein, et al.
Annals of Clinical and Translational Neurology|August 4, 2025
Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment ResponseMaximilian Einsiedler, Aleksandra Maleska Maceski, Sofia Sandgren, et al.
Pageof 3